Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

More than 50% of human cancers contain p53 gene mutations and as a result accumulate altered forms of the full-length p53 protein. Although certain tumor types expressing mutant p53 protein have a poor prognostic process, the precise role of mutant p53 protein in highly malignant tumor cells is not...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	Mol Cell Biol
Egile Nagusiak:	Ohiro, Yoichi, Usheva, Anny, Kobayashi, Shinichiro, Duffy, Shannon L., Nantz, Regan, Gius, David, Horikoshi, Nobuo
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Taylor & Francis 2003
Gaiak:	Cell Growth and Development
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140653/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12482984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/MCB.23.1.322-334.2003
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

Antzeko izenburuak